Tethys Bioscience is dedicated to the discovery, development and commercialization of novel biological markers – biomarkers – that provide a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes.

Our research strategies lead to sets of biomarkers that can be used to quantify the level of an individual’s risk.  Our goal is to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit.

Tethys Bioscience approaches the market with a unique combination of strengths:

• A management, research, and commercialization team with extensive experience in diagnostic innovation
• Alliances with world-class researchers and vendors
• A solid financial foundation

 Tethys Bioscience is uniquely positioned to help transform the management of chronic diseases with personalized and preventive solutions that aid patients, doctors and every other constituency in the healthcare system.